Delek US director sells 29,372 shares in plan

Delek US Holdings director Zohar Shlomo reported open‑market sales of company common stock under a pre‑arranged trading plan.

Rhea-AI Filing Summary

Delek US Holdings director Zohar Shlomo reported open‑market sales of company common stock under a pre‑arranged trading plan. On March 4–5, 2026, he sold a total of 29,372 shares of Delek US Holdings common stock in several transactions at prices between $43.00 and $45.50 per share. Following these sales, he directly owned 18,989 shares of the company’s common stock. The filing notes that these transactions were made pursuant to a Rule 10b5‑1 trading plan adopted on November 13, 2025, intended to satisfy the affirmative defense conditions of Rule 10b5‑1(c).

Insider Trade Summary

Net Seller: 29,372 shares

Net Sell 4 txns

Insider Zohar Shlomo

Role Director

Sold 29,372 shs ($1.30M)

Type	Security	Shares	Price	Value
Sale	Common Stock	7,343	$44.00	$323K
Sale	Common Stock	7,343	$45.00	$330K
Sale	Common Stock	7,343	$45.50	$334K
Sale	Common Stock	7,343	$43.00	$316K

Holdings After Transaction: Common Stock — 18,989 shares (Direct)

Footnotes (1)

1. F1. This transaction was made pursuant to a 10b5-1 plan adopted on November 13, 2025, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Delek US (DK) director Zohar Shlomo report in this Form 4?

Director Zohar Shlomo reported selling Delek US common stock in open-market transactions. The Form 4 discloses multiple sales made on March 4–5, 2026 under a pre-arranged Rule 10b5-1 trading plan adopted on November 13, 2025.

How many Delek US (DK) shares did Zohar Shlomo sell and on what dates?

He sold a total of 29,372 Delek US common shares. The reported transactions occurred on March 4 and March 5, 2026, with four separate sale entries of 7,343 shares each, all classified as open-market sales of common stock.

At what prices were the Delek US (DK) shares sold by Zohar Shlomo?

The reported sale prices ranged from $43.00 to $45.50 per share. Individual transactions were executed at $43.00, $44.00, $45.00, and $45.50, reflecting multiple open-market sales of 7,343 shares each over two consecutive trading days.

How many Delek US (DK) shares does Zohar Shlomo hold after these transactions?

After the reported sales, he directly holds 18,989 Delek US common shares. This post-transaction balance reflects the cumulative effect of four separate open-market sale transactions disclosed in the filing, each reducing his directly owned share count.

Were the Delek US (DK) share sales by Zohar Shlomo under a 10b5-1 trading plan?

Yes. The filing states the transactions were made pursuant to a 10b5-1 plan adopted on November 13, 2025. It notes the plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) for pre-arranged trading.

What type of transactions did Delek US (DK) director Zohar Shlomo report?

He reported open-market sales of common stock, coded “S” on Form 4. All four transactions involved non-derivative common shares and are described as sales in the open market or private transactions, with direct ownership reported after each sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 09:17 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zohar Shlomo

(Last) (First) (Middle)

310 SEVEN SPRINGS WAY

SUITE 500

(Street)

BRENTWOOD TN 37027

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Delek US Holdings, Inc. [ DK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		S(1)		7,343	D	$43	41,018	D
Common Stock	03/05/2026		S(1)		7,343	D	$44	33,675	D
Common Stock	03/05/2026		S(1)		7,343	D	$45	26,332	D
Common Stock	03/05/2026		S(1)		7,343	D	$45.5	18,989	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was made pursuant to a 10b5-1 plan adopted on November 13, 2025, and is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Remarks:

	/s/ Misty Lavender, Attorney in Fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.